162 related articles for article (PubMed ID: 23625595)
1. PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions.
Waniczek D; Śnietura M; Młynarczyk-Liszka J; Pigłowski W; Kopeć A; Lange D; Rudzki M; Arendt J
Pol J Pathol; 2013 Apr; 64(1):15-20. PubMed ID: 23625595
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma.
Jang KS; Song YS; Jang SH; Min KW; Na W; Jang SM; Jun YJ; Lee KH; Choi D; Paik SS
Histopathology; 2010 Jan; 56(2):229-39. PubMed ID: 20102402
[TBL] [Abstract][Full Text] [Related]
4. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
5. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
Xiong B; Cheng Y; Ma L; Zhang C
Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological aspects of endoscopic resections of colorectal polyps in patients at an endoscopy training center in the Santos region, Brasil.
Filho TF; Fávaro GM; Coca DS; Daniel LB; Guenaga KF; Sato Uemura R; Furuya Junior CK; Artifon ELA
Rev Gastroenterol Peru; 2017; 37(1):47-52. PubMed ID: 28489836
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
[TBL] [Abstract][Full Text] [Related]
9. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.
Kurihara H; Maruyama R; Ishiguro K; Kanno S; Yamamoto I; Ishigami K; Mitsuhashi K; Igarashi H; Ito M; Tanuma T; Sukawa Y; Okita K; Hasegawa T; Imai K; Yamamoto H; Shinomura Y; Nosho K
Oncotarget; 2016 Mar; 7(11):12704-17. PubMed ID: 26871294
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer.
Marsh Durban V; Jansen M; Davies EJ; Morsink FH; Offerhaus GJ; Clarke AR
Am J Pathol; 2014 Jan; 184(1):86-91. PubMed ID: 24200851
[TBL] [Abstract][Full Text] [Related]
11. Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
Simsek BC; Pehlivan S; Karaoglu A
Ann Diagn Pathol; 2010 Dec; 14(6):413-7. PubMed ID: 21074689
[TBL] [Abstract][Full Text] [Related]
12. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway.
Sun Y; Tian H; Wang L
Oncol Rep; 2015 Apr; 33(4):1828-36. PubMed ID: 25683168
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.
Ieda S; Watatani M; Yoshida T; Kuroda K; Inui H; Yasutomi M
Surg Today; 1996; 26(4):230-5. PubMed ID: 8727942
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
[TBL] [Abstract][Full Text] [Related]
15. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
16. [Autoregulatory growth control of adenomatous polyps and carcinogenesis in the colorectal region. Basics of tumor surgery Part I].
Stelzner F
Chirurg; 2006 Nov; 77(11):1048-55. PubMed ID: 17068665
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
18. Expression of PI3K, PTEN and Akt in small intestinal adenocarcinoma detected by quantum dots-based immunofluorescence technology.
Zhang Y; Yao X; Jiang C; Yue J; Guan J; Cheng H; Hajirashid M; Wang Y; Fan L
Cancer Biomark; 2013; 13(4):299-305. PubMed ID: 24240591
[TBL] [Abstract][Full Text] [Related]
19. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
